Cargando…

Molecular Biology and Clinical Management of Esophageal Adenocarcinoma

SIMPLE SUMMARY: Esophageal adenocarcinoma (EAC) is one of the two main subtypes of esophageal cancer. EAC is a highly lethal disease with rising incidence in Western countries. EAC is associated with chronic gastroesophageal reflux disease and Barrett’s esophagus and mostly occurs in the distal esop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shulin, Hoefnagel, Sanne Johanna Maria, Krishnadath, Kausilia Krishnawatie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670638/ https://www.ncbi.nlm.nih.gov/pubmed/38001670 http://dx.doi.org/10.3390/cancers15225410

Ejemplares similares

Single domain Camelid antibody fragments for molecular imaging and therapy of cancer
por: Li, Shulin, et al.
Publicado: (2023)

Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens
por: Hoefnagel, Sanne J. M., et al.
Publicado: (2021)

Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models
por: Li, Shulin, et al.
Publicado: (2022)

Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis
por: Liu, David S., et al.
Publicado: (2016)

Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies
por: Hoefnagel, Sanne J. M., et al.
Publicado: (2022)

Trastuzumab Mediated T-Cell Response against HER-2/Neu Overexpressing Esophageal Adenocarcinoma Depends on Intact Antigen Processing Machinery
por: Milano, Francesca, et al.
Publicado: (2010)

Detection of circulating BMP5 as a risk factor for Barrett’s esophagus
por: Correia, Ana C. P., et al.
Publicado: (2020)

Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response
por: Milano, Francesca, et al.
Publicado: (2013)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
por: van Baal, Jantine W. P. M., et al.
Publicado: (2008)

Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
por: Orsini, Arianna, et al.
Publicado: (2023)

Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations
por: Isidori, Federica, et al.
Publicado: (2020)

The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma
por: Fiocca, Roberto, et al.
Publicado: (2021)

The dynamics of HER2 status in esophageal adenocarcinoma
por: Creemers, Aafke, et al.
Publicado: (2018)

Inhibition of the BMP pathway prevents development of Barrett’s-associated adenocarcinoma in a surgical rat model
por: Westra, Wytske M, et al.
Publicado: (2021)

Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
por: Ykema, Berbel L. M., et al.
Publicado: (2020)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report
por: Isidori, Federica, et al.
Publicado: (2018)

A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas
por: Creemers, Aafke, et al.
Publicado: (2018)

Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar Lesions
por: Correia, Ana C. P., et al.
Publicado: (2021)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma
por: Williams, L.J., et al.
Publicado: (2006)

Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors
por: Calpe, Silvia, et al.
Publicado: (2016)

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
por: Ebbing, Eva A., et al.
Publicado: (2019)

Controversies in the surgical management of esophageal adenocarcinoma
por: Worrell, Stephanie G., et al.
Publicado: (2023)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
por: Khalafi, Shayan, et al.
Publicado: (2020)

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
por: Wang, Shun, et al.
Publicado: (2021)

Advances in the management of Barrett’s esophagus and early esophageal adenocarcinoma
por: Singh, Ajaypal, et al.
Publicado: (2015)

Chemoprevention of esophageal adenocarcinoma
por: Snider, Erik J, et al.
Publicado: (2020)

Artificial Intelligence in the Management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2022)

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
por: Gelsomino, Fabio, et al.
Publicado: (2022)

Optimal Clinical Management and the Molecular Biology of Angiosarcomas
por: Chen, Tom Wei-Wu, et al.
Publicado: (2020)

Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett’s Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives
por: Majka, Jolanta, et al.
Publicado: (2018)

Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019)

The molecular biology of peritoneal metastatic disease
por: Bootsma, Sanne, et al.
Publicado: (2023)

Esophageal adenocarcinoma: Methods and protocols
por: Samarasam, Inian
Publicado: (2019)

Emerging therapeutic targets in esophageal adenocarcinoma
por: Gaur, Puja, et al.
Publicado: (2016)

The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma
por: Gillespie, Megan R., et al.
Publicado: (2021)

Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma
por: Hoppe, Sascha, et al.
Publicado: (2021)

Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021)

Extracellular miRNAs for the Management of Barrett’s Esophagus and Esophageal Adenocarcinoma: A Systematic Review
por: Inokuchi, Kazumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ei7l7t7v75bi104qq4tps91ha